Miranda Cornet

Phase I and phase II xenobiotic biotransformation in cultures and co-cultures of adult rat hepatocytes

Vera Rogiers, Yves Vandenberghe, A. Callaerts et al. · Biochemical Pharmacology · 1990 · 80 citations

Biotransformation, Biochemistry, Natural Sciences +11

Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: A preliminary study using a multiplexing approach

Helga H.J. Gerets, Étienne Hanon, Miranda Cornet et al. · Toxicology in Vitro · 2008 · 70 citations

Medicinal Chemistry, New Chemical Entities, Pharmaceutical Research +14

Determination of Phospholipidosis Potential Based on Gene Expression Analysis in HepG2 Cells

Franck Atienzar, Helga H.J. Gerets, Simon Dufrane et al. · Toxicological Sciences · 2006 · 45 citations · Full text

Use of a physiologically based pharmacokinetic–pharmacodynamic model for initial dose prediction and escalation during a paediatric clinical trial

Trevor N. Johnson, Khaled Abduljalil, Jean‐Marie Nicolas et al. · British Journal of Clinical Pharmacology · 2020 · 22 citations · Full text

Investigative safety strategies to improve success in drug development

Franck Atienzar, Annie Delaunois, Frédéric Brouta et al. · JOURNAL OF MEDICINES DEVELOPMENT SCIENCES · 2016 · 14 citations · Full text

Drug Safety, Systems Pharmacology, Pharmacokinetic Modeling +14